{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:02:58Z","timestamp":1790431378968,"version":"4.1.0"},"reference-count":228,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1038\/s41585-023-00754-x","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T09:04:07Z","timestamp":1680685447000},"page":"434-451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Genetic control of typical and atypical sex development"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8528-7623","authenticated-orcid":false,"given":"Alejandra P.","family":"Reyes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8009-0872","authenticated-orcid":false,"given":"Nayla Y.","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8696-2136","authenticated-orcid":false,"given":"Emily R.","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2405-1262","authenticated-orcid":false,"given":"Vincent R.","family":"Harley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"754_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jpag.2020.11.012","volume":"34","author":"L Duranteau","year":"2021","unstructured":"Duranteau, L. et al. Participant- and clinician-reported long-term outcomes after surgery in individuals with complete androgen insensitivity syndrome. J. Pediatr. Adolesc. Gynecol. 34, 168\u2013175 (2021).","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"754_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jpurol.2006.03.004","volume":"2","author":"IA Hughes","year":"2006","unstructured":"Hughes, I. A., Houk, C., Ahmed, S. F. & Lee, P. A., Lawson Wilkins Pediatric Endocrine Society\/European Society for Paediatric Endocrinology Consensus Group. Consensus statement on management of intersex disorders. J. Pediatr. Urol. 2, 148\u2013162 (2006).","journal-title":"J. Pediatr. Urol."},{"key":"754_CR3","doi-asserted-by":"publisher","first-page":"e488","DOI":"10.1542\/peds.2006-0738","volume":"118","author":"PA Lee","year":"2006","unstructured":"Lee, P. A. et al. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics 118, e488\u2013e500 (2006).","journal-title":"Pediatrics"},{"key":"754_CR4","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/cen.14528","volume":"95","author":"SF Ahmed","year":"2021","unstructured":"Ahmed, S. F. et al. Society for endocrinology UK Guidance on the initial evaluation of a suspected difference or disorder of sex development (revised 2021). Clin. Endocrinol. 95, 818\u2013840 (2021).","journal-title":"Clin. Endocrinol."},{"key":"754_CR5","doi-asserted-by":"publisher","first-page":"R197","DOI":"10.1530\/EJE-18-0256","volume":"179","author":"L Audi","year":"2018","unstructured":"Audi, L. et al. Genetics in endocrinology: approaches to molecular genetic diagnosis in the management of differences\/disorders of sex development (DSD): position paper of EU COST Action BM 1303 \u2018DSDnet\u2019. Eur. J. Endocrinol. 179, R197\u2013R206 (2018).","journal-title":"Eur. J. Endocrinol."},{"key":"754_CR6","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1038\/s41431-018-0202-7","volume":"26","author":"N Camats","year":"2018","unstructured":"Camats, N., Fernandez-Cancio, M., Audi, L., Schaller, A. & Fluck, C. E. Broad phenotypes in heterozygous NR5A1 46,XY patients with a disorder of sex development: an oligogenic origin? Eur. J. Hum. Genet. 26, 1329\u20131338 (2018).","journal-title":"Eur. J. Hum. Genet."},{"key":"754_CR7","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/S2213-8587(18)30339-5","volume":"7","author":"NY Leon","year":"2019","unstructured":"Leon, N. Y., Reyes, A. P. & Harley, V. R. A clinical algorithm to diagnose differences of sex development. Lancet Diabetes Endocrinol. 7, 560\u2013574 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"754_CR8","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s12020-021-02748-4","volume":"73","author":"GL Kavanaugh","year":"2021","unstructured":"Kavanaugh, G. L. et al. \u201cGood practices\u201d in pediatric clinical care for disorders\/differences of sex development. Endocrine 73, 723\u2013733 (2021).","journal-title":"Endocrine"},{"key":"754_CR9","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.tig.2019.02.004","volume":"35","author":"I Stevant","year":"2019","unstructured":"Stevant, I. & Nef, S. Genetic control of gonadal sex determination and development. Trends Genet. 35, 346\u2013358 (2019).","journal-title":"Trends Genet."},{"key":"754_CR10","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/humrep\/deaa041","volume":"35","author":"E Lecluze","year":"2020","unstructured":"Lecluze, E. et al. Dynamics of the transcriptional landscape during human fetal testis and ovary development. Hum. Reprod. 35, 1099\u20131119 (2020).","journal-title":"Hum. Reprod."},{"key":"754_CR11","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1101\/gad.220102","volume":"16","author":"D Wilhelm","year":"2002","unstructured":"Wilhelm, D. & Englert, C. The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1. Genes Dev. 16, 1839\u20131851 (2002).","journal-title":"Genes Dev."},{"key":"754_CR12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1101\/gad.13.7.755","volume":"13","author":"A Swain","year":"1999","unstructured":"Swain, A. & Lovell-Badge, R. Mammalian sex determination: a molecular drama. Genes Dev. 13, 755\u2013767 (1999).","journal-title":"Genes Dev."},{"key":"754_CR13","doi-asserted-by":"publisher","DOI":"10.1242\/dev.199208","author":"C Bunce","year":"2021","unstructured":"Bunce, C., McKey, J. & Capel, B. Concerted morphogenesis of genital ridges and nephric ducts in the mouse captured through whole-embryo imaging. Development https:\/\/doi.org\/10.1242\/dev.199208 (2021).","journal-title":"Development"},{"key":"754_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1006\/dbio.2001.0438","volume":"240","author":"KH Albrecht","year":"2001","unstructured":"Albrecht, K. H. & Eicher, E. M. Evidence that Sry is expressed in Pre-Sertoli cells and Sertoli and granulosa cells have a common precursor. Dev. Biol. 240, 92\u2013107 (2001).","journal-title":"Dev. Biol."},{"key":"754_CR15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0925-4773(99)00307-X","volume":"91","author":"NA Hanley","year":"2000","unstructured":"Hanley, N. A. et al. SRY, SOX9, and DAX1 expression patterns during human sex determination and gonadal development. Mech. Dev. 91, 403\u2013407 (2000).","journal-title":"Mech. Dev."},{"key":"754_CR16","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-022-04918-4","volume":"607","author":"L Garcia-Alonso","year":"2022","unstructured":"Garcia-Alonso, L. et al. Single-cell roadmap of human gonadal development. Nature 607, 540\u2013547 (2022).","journal-title":"Nature"},{"key":"754_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003629","volume":"9","author":"Y-C Hu","year":"2013","unstructured":"Hu, Y.-C., Okumura, L. M. & Page, D. C. Gata4 is required for formation of the genital ridge in mice. PLoS Genet. 9, e1003629 (2013).","journal-title":"PLoS Genet."},{"key":"754_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrm2815","volume":"11","author":"BE Richardson","year":"2010","unstructured":"Richardson, B. E. & Lehmann, R. Mechanisms guiding primordial germ cell migration: strategies from different organisms. Nat. Rev. Mol. Cell Biol. 11, 37\u201349 (2010).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"754_CR19","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1242\/dev.124.9.1653","volume":"124","author":"N Miyamoto","year":"1997","unstructured":"Miyamoto, N., Yoshida, M., Kuratani, S., Matsuo, I. & Aizawa, S. Defects of urogenital development in mice lacking Emx2. Development 124, 1653\u20131664 (1997).","journal-title":"Development"},{"key":"754_CR20","doi-asserted-by":"publisher","first-page":"5893","DOI":"10.1210\/en.2010-0915","volume":"151","author":"M Kusaka","year":"2010","unstructured":"Kusaka, M. et al. Abnormal epithelial cell polarity and ectopic epidermal growth factor receptor (EGFR) expression induced in Emx2 KO embryonic gonads. Endocrinology 151, 5893\u20135904 (2010).","journal-title":"Endocrinology"},{"key":"754_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002575","volume":"8","author":"SA Jameson","year":"2012","unstructured":"Jameson, S. A. et al. Temporal transcriptional profiling of somatic and germ cells reveals biased lineage priming of sexual fate in the fetal mouse gonad. PLoS Genet. 8, e1002575 (2012).","journal-title":"PLoS Genet."},{"key":"754_CR22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000108930","volume":"1","author":"H Ostrer","year":"2007","unstructured":"Ostrer, H., Huang, H. Y., Masch, R. J. & Shapiro, E. A cellular study of human testis development. Sex. Dev. 1, 286\u2013292 (2007).","journal-title":"Sex. Dev."},{"key":"754_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/gene.10235","volume":"37","author":"CA Schnabel","year":"2003","unstructured":"Schnabel, C. A., Selleri, L. & Cleary, M. L. Pbx1 is essential for adrenal development and urogenital differentiation. Genesis 37, 123\u2013130 (2003).","journal-title":"Genesis"},{"key":"754_CR24","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1242\/dev.048819","volume":"137","author":"TD Capellini","year":"2010","unstructured":"Capellini, T. D. et al. Scapula development is governed by genetic interactions of Pbx1 with its family members and with Emx2 via their cooperative control of Alx1. Development 137, 2559\u20132569 (2010).","journal-title":"Development"},{"key":"754_CR25","first-page":"1071","volume":"40","author":"C Eozenou","year":"2019","unstructured":"Eozenou, C. et al. The TALE homeodomain of PBX1 is involved in human primary testis-determination. Hum. Mutat. 40, 1071\u20131076 (2019).","journal-title":"Hum. Mutat."},{"key":"754_CR26","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.ajhg.2009.03.016","volume":"84","author":"A Biason-Lauber","year":"2009","unstructured":"Biason-Lauber, A., Konrad, D., Meyer, M., DeBeaufort, C. & Schoenle, E. J. Ovaries and female phenotype in a girl with 46,XY karyotype and mutations in the CBX2 gene. Am. J. Hum. Genet. 84, 658\u2013663 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"754_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000522164","volume":"16","author":"D Hart","year":"2022","unstructured":"Hart, D., Rodr\u00edguez Guti\u00e9rrez, D. & Biason-Lauber, A. CBX2 in DSD: the quirky kid on the block. Sex. Dev. 16, 162\u2013170 (2022).","journal-title":"Sex. Dev."},{"key":"754_CR28","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/35002622","volume":"403","author":"OS Birk","year":"2000","unstructured":"Birk, O. S. et al. The LIM homeobox gene Lhx9 is essential for mouse gonad formation. Nature 403, 909\u2013913 (2000).","journal-title":"Nature"},{"key":"754_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrendo.2012.235","volume":"9","author":"M Ono","year":"2013","unstructured":"Ono, M. & Harley, V. R. Disorders of sex development: new genes, new concepts. Nat. Rev. Endocrinol. 9, 79\u201391 (2013).","journal-title":"Nat. Rev. Endocrinol."},{"key":"754_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.beem.2010.08.013","volume":"25","author":"RA Rey","year":"2011","unstructured":"Rey, R. A. & Grinspon, R. P. Normal male sexual differentiation and aetiology of disorders of sex development. Best. Pract. Res. Clin. Endocrinol. Metab. 25, 221\u2013238 (2011).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"754_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.tig.2008.10.008","volume":"25","author":"R Sekido","year":"2009","unstructured":"Sekido, R. & Lovell-Badge, R. Sex determination and SRY: down to a wink and a nudge? Trends Genet. 25, 19\u201329 (2009).","journal-title":"Trends Genet."},{"key":"754_CR32","doi-asserted-by":"publisher","first-page":"1086276","DOI":"10.3389\/fendo.2022.1086276","volume":"13","author":"I Bhattacharya","year":"2022","unstructured":"Bhattacharya, I. & Dey, S. Emerging concepts on Leydig cell development in fetal and adult testis. Front. Endocrinol. 13, 1086276 (2022).","journal-title":"Front. Endocrinol."},{"key":"754_CR33","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/molehr\/gap073","volume":"15","author":"C Tingen","year":"2009","unstructured":"Tingen, C., Kim, A. & Woodruff, T. K. The primordial pool of follicles and nest breakdown in mammalian ovaries. Mol. Hum. Reprod. 15, 795\u2013803 (2009).","journal-title":"Mol. Hum. Reprod."},{"key":"754_CR34","doi-asserted-by":"publisher","first-page":"R205","DOI":"10.1530\/REP-13-0181","volume":"146","author":"JB Kerr","year":"2013","unstructured":"Kerr, J. B., Myers, M. & Anderson, R. A. The dynamics of the primordial follicle reserve. Reproduction 146, R205\u2013R215 (2013).","journal-title":"Reproduction"},{"key":"754_CR35","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1530\/REP-10-0094","volume":"140","author":"JM Young","year":"2010","unstructured":"Young, J. M. & McNeilly, A. S. Theca: the forgotten cell of the ovarian follicle. Reproduction 140, 489\u2013504 (2010).","journal-title":"Reproduction"},{"key":"754_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7934","volume":"6","author":"C Liu","year":"2015","unstructured":"Liu, C., Peng, J., Matzuk, M. M. & Yao, H. H. Lineage specification of ovarian theca cells requires multicellular interactions via oocyte and granulosa cells. Nat. Commun. 6, 6934 (2015).","journal-title":"Nat. Commun."},{"key":"754_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119800","volume":"10","author":"N Hatzirodos","year":"2015","unstructured":"Hatzirodos, N., Hummitzsch, K., Irving-Rodgers, H. F. & Rodgers, R. J. Transcriptome comparisons identify new cell markers for theca interna and granulosa cells from small and large antral ovarian follicles. PLoS ONE\u00a010, e0119800 (2015).","journal-title":"PLoS ONE"},{"key":"754_CR38","doi-asserted-by":"publisher","first-page":"9618","DOI":"10.1073\/pnas.88.21.9618","volume":"88","author":"DA Haber","year":"1991","unstructured":"Haber, D. A. et al. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc. Natl Acad. Sci. USA 88, 9618\u20139622 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"754_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0092-8674(01)00453-6","volume":"106","author":"A Hammes","year":"2001","unstructured":"Hammes, A. et al. Two splice variants of the Wilms\u2019 tumor 1 gene have distinct functions during sex determination and nephron formation. Cell 106, 319\u2013329 (2001).","journal-title":"Cell"},{"key":"754_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/biology10121248","author":"D Sirokha","year":"2021","unstructured":"Sirokha, D. et al. A novel WT1 mutation identified in a 46,XX testicular\/ovotesticular DSD patient results in the retention of Intron 9. Biology https:\/\/doi.org\/10.3390\/biology10121248 (2021).","journal-title":"Biology"},{"key":"754_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcdb.2016.07.032","volume":"63","author":"ZY She","year":"2017","unstructured":"She, Z. Y. & Yang, W. X. Sry and SoxE genes: how they participate in mammalian sex determination and gonadal development? Semin. Cell Dev. Biol. 63, 13\u201322 (2017).","journal-title":"Semin. Cell Dev. Biol."},{"key":"754_CR42","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000452637","volume":"10","author":"A Bashamboo","year":"2016","unstructured":"Bashamboo, A. & McElreavey, K. Mechanism of sex determination in humans: insights from disorders of sex development. Sex. Dev. 10, 313\u2013325 (2016).","journal-title":"Sex. Dev."},{"key":"754_CR43","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.eururo.2014.07.011","volume":"67","author":"YG van der Zwan","year":"2015","unstructured":"van der Zwan, Y. G., Biermann, K., Wolffenbuttel, K. P., Cools, M. & Looijenga, L. H. Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model. Eur. Urol. 67, 692\u2013701 (2015).","journal-title":"Eur. Urol."},{"key":"754_CR44","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1210\/en.2017-00674","volume":"158","author":"S Bagheri-Fam","year":"2017","unstructured":"Bagheri-Fam, S. et al. Testis determination requires a specific FGFR2 isoform to repress FOXL2. Endocrinology 158, 3832\u20133843 (2017).","journal-title":"Endocrinology"},{"key":"754_CR45","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13293-018-0167-9","volume":"9","author":"H Barseghyan","year":"2018","unstructured":"Barseghyan, H. et al. Identification of novel candidate genes for 46,XY disorders of sex development (DSD) using a C57BL\/6J-Y (POS) mouse model. Biol. Sex. Differ. 9, 8 (2018).","journal-title":"Biol. Sex. Differ."},{"key":"754_CR46","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/humu.23353","volume":"39","author":"H Fabbri-Scallet","year":"2018","unstructured":"Fabbri-Scallet, H. et al. Functional characterization of five NR5A1 gene mutations found in patients with 46,XY disorders of sex development. Hum. Mutat. 39, 114\u2013123 (2018).","journal-title":"Hum. Mutat."},{"key":"754_CR47","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ajmg.c.31559","volume":"175","author":"A Granados","year":"2017","unstructured":"Granados, A. et al. MAP3K1-related gonadal dysgenesis: six new cases and review of the literature. Am. J. Med. Genet. C. Semin. Med. Genet. 175, 253\u2013259 (2017).","journal-title":"Am. J. Med. Genet. C. Semin. Med. Genet."},{"key":"754_CR48","doi-asserted-by":"publisher","first-page":"17011","DOI":"10.1038\/hgv.2017.11","volume":"4","author":"A Hagan","year":"2017","unstructured":"Hagan, A. & Amarillo, I. E. Small copy-number variations involving genes of the FGF pathway in differences in sex development. Hum. Genome Var. 4, 17011 (2017).","journal-title":"Hum. Genome Var."},{"key":"754_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007034","volume":"13","author":"S Kuroki","year":"2017","unstructured":"Kuroki, S. et al. Rescuing the aberrant sex development of H3K9 demethylase Jmjd1a-deficient mice by modulating H3K9 methylation balance. PLoS Genet. 13, e1007034 (2017).","journal-title":"PLoS Genet."},{"key":"754_CR50","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1126\/science.aai9136","volume":"357","author":"F Zhao","year":"2017","unstructured":"Zhao, F. et al. Elimination of the male reproductive tract in the female embryo is promoted by COUP-TFII in mice. Science 357, 717\u2013720 (2017).","journal-title":"Science"},{"key":"754_CR51","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1093\/hmg\/ddi210","volume":"14","author":"C Ottolenghi","year":"2005","unstructured":"Ottolenghi, C. et al. Foxl2 is required for commitment to ovary differentiation. Hum. Mol. Genet. 14, 2053\u20132062 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"754_CR52","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1093\/hmg\/ddn016","volume":"17","author":"AA Chassot","year":"2008","unstructured":"Chassot, A. A. et al. Activation of \u03b2-catenin signaling by Rspo1 controls differentiation of the mammalian ovary. Hum. Mol. Genet. 17, 1264\u20131277 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"754_CR53","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1530\/REP-14-0177","volume":"148","author":"AA Chassot","year":"2014","unstructured":"Chassot, A. A., Gillot, I. & Chaboissier, M. C. R-spondin1, WNT4, and the CTNNB1 signaling pathway: strict control over ovarian differentiation. Reproduction 148, R97\u2013R110 (2014).","journal-title":"Reproduction"},{"key":"754_CR54","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000357956","volume":"8","author":"T Ohnesorg","year":"2014","unstructured":"Ohnesorg, T., Vilain, E. & Sinclair, A. H. The genetics of disorders of sex development in humans. Sex. Dev. 8, 262\u2013272 (2014).","journal-title":"Sex. Dev."},{"key":"754_CR55","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrendo.2014.130","volume":"10","author":"VA Arboleda","year":"2014","unstructured":"Arboleda, V. A., Sandberg, D. E. & Vilain, E. DSDs: genetics, underlying pathologies and psychosexual differentiation. Nat. Rev. Endocrinol. 10, 603\u2013615 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"754_CR56","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000448667","volume":"10","author":"M Pannetier","year":"2016","unstructured":"Pannetier, M., Chassot, A. A., Chaboissier, M. C. & Pailhoux, E. Involvement of FOXL2 and RSPO1 in ovarian determination, development, and maintenance in mammals. Sex. Dev. 10, 167\u2013184 (2016).","journal-title":"Sex. Dev."},{"key":"754_CR57","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1677\/jme.1.01947","volume":"36","author":"M Pannetier","year":"2006","unstructured":"Pannetier, M. et al. FOXL2 activates P450 aromatase gene transcription: towards a better characterization of the early steps of mammalian ovarian development. J. Mol. Endocrinol. 36, 399\u2013413 (2006).","journal-title":"J. Mol. Endocrinol."},{"key":"754_CR58","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.cell.2009.11.021","volume":"139","author":"NH Uhlenhaut","year":"2009","unstructured":"Uhlenhaut, N. H. et al. Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell 139, 1130\u20131142 (2009).","journal-title":"Cell"},{"key":"754_CR59","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000519836","volume":"16","author":"EJ Tucker","year":"2022","unstructured":"Tucker, E. J. The genetics and biology of FOXL2. Sex. Dev. 16, 184\u2013193 (2022).","journal-title":"Sex. Dev."},{"key":"754_CR60","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.83291","volume":"12","author":"MD Pierson Smela","year":"2023","unstructured":"Pierson Smela, M. D. et al. Directed differentiation of human iPSCs to functional ovarian granulosa-like cells via transcription factor overexpression. Elife 12, e83291 (2023).","journal-title":"Elife"},{"key":"754_CR61","doi-asserted-by":"publisher","first-page":"906381","DOI":"10.3389\/fendo.2022.906381","volume":"13","author":"NY Edelsztein","year":"2022","unstructured":"Edelsztein, N. Y., Valeri, C., Lovaisa, M. M., Schteingart, H. F. & Rey, R. A. AMH regulation by steroids in the mammalian testis: underlying mechanisms and clinical implications. Front. Endocrinol. 13, 906381 (2022).","journal-title":"Front. Endocrinol."},{"key":"754_CR62","first-page":"379","volume":"8","author":"A Jost","year":"1953","unstructured":"Jost, A. Problems of fetal endocrinology: the gonadal and hypophyseal hormones. Recent. Progr Horm. Res. 8, 379\u2013413 (1953).","journal-title":"Recent. Progr Horm. Res."},{"key":"754_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/wdev.310","volume":"7","author":"ZY Roly","year":"2018","unstructured":"Roly, Z. Y. et al. The cell biology and molecular genetics of Mullerian duct development. Wiley Interdiscip. Rev. Dev. Biol. 7, e310 (2018).","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"key":"754_CR64","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1210\/edrv-11-4-532","volume":"11","author":"J Rabinovici","year":"1990","unstructured":"Rabinovici, J. & Jaffe, R. B. Development and regulation of growth and differentiated function in human and subhuman primate fetal gonads. Endocr. Rev. 11, 532\u2013557 (1990).","journal-title":"Endocr. Rev."},{"key":"754_CR65","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/978-3-319-31973-5_13","volume":"58","author":"A Biason-Lauber","year":"2016","unstructured":"Biason-Lauber, A. The battle of the sexes: human sex development and its disorders. Results Probl. Cell Differ. 58, 337\u2013382 (2016).","journal-title":"Results Probl. Cell Differ."},{"key":"754_CR66","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jsbmb.2016.05.020","volume":"163","author":"BB Mendonca","year":"2016","unstructured":"Mendonca, B. B. et al. Steroid 5\u03b1-reductase 2 deficiency. J. Steroid Biochem. Mol. Biol. 163, 206\u2013211 (2016).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"754_CR67","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/andr.12156","volume":"4","author":"A Thankamony","year":"2016","unstructured":"Thankamony, A., Pasterski, V., Ong, K. K., Acerini, C. L. & Hughes, I. A. Anogenital distance as a marker of androgen exposure in humans. Andrology 4, 616\u2013625 (2016).","journal-title":"Andrology"},{"key":"754_CR68","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1095\/biolreprod.110.087197","volume":"83","author":"JJ Tremblay","year":"2010","unstructured":"Tremblay, J. J. What signals testis descent? Biol. Reprod. 83, 687\u2013689 (2010).","journal-title":"Biol. Reprod."},{"key":"754_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000198","volume":"17","author":"WL Miller","year":"2019","unstructured":"Miller, W. L. & Auchus, R. J. The \u201cbackdoor pathway\u201d of androgen synthesis in human male sexual development. PLoS Biol. 17, e3000198 (2019).","journal-title":"PLoS Biol."},{"key":"754_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000002","volume":"17","author":"PJ O\u2019Shaughnessy","year":"2019","unstructured":"O\u2019Shaughnessy, P. J. et al. Alternative (backdoor) androgen production and masculinization in the human fetus. PLoS Biol. 17, e3000002 (2019).","journal-title":"PLoS Biol."},{"key":"754_CR71","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nrurol.2011.23","volume":"8","author":"K Bay","year":"2011","unstructured":"Bay, K., Main, K. M., Toppari, J. & Skakkebaek, N. E. Testicular descent: INSL3, testosterone, genes and the intrauterine milieu. Nat. Rev. Urol. 8, 187\u2013196 (2011).","journal-title":"Nat. Rev. Urol."},{"key":"754_CR72","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(85)92739-4","volume":"2","author":"JM Hutson","year":"1985","unstructured":"Hutson, J. M. A biphasic model for the hormonal control of testicular descent. Lancet 2, 419\u2013421 (1985).","journal-title":"Lancet"},{"key":"754_CR73","first-page":"93","volume":"153","author":"CF Heyns","year":"1987","unstructured":"Heyns, C. F. The gubernaculum during testicular descent in the human fetus. J. Anat. 153, 93\u2013112 (1987).","journal-title":"J. Anat."},{"key":"754_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-58353-7_1","volume":"156","author":"KJ Barteczko","year":"2000","unstructured":"Barteczko, K. J. & Jacob, M. I. The testicular descent in human. Origin, development and fate of the gubernaculum Hunteri, processus vaginalis peritonei, and gonadal ligaments. Adv. Anat. Embryol. Cell Biol. 156, 1\u201398 (2000).","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"key":"754_CR75","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1210\/er.2012-1089","volume":"34","author":"JM Hutson","year":"2013","unstructured":"Hutson, J. M. et al. The regulation of testicular descent and the effects of cryptorchidism. Endocr. Rev. 34, 725\u2013752 (2013).","journal-title":"Endocr. Rev."},{"key":"754_CR76","doi-asserted-by":"publisher","first-page":"101634","DOI":"10.1016\/j.beem.2022.101634","volume":"36","author":"N Josso","year":"2022","unstructured":"Josso, N. & Picard, J. Y. Genetics of anti-Mullerian hormone and its signaling pathway. Best. Pract. Res. Clin. Endocrinol. Metab. 36, 101634 (2022).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"754_CR77","first-page":"3836","volume":"84","author":"E Rajpert-De Meyts","year":"1999","unstructured":"Rajpert-De Meyts, E. et al. Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J. Clin. Endocrinol. Metab. 84, 3836\u20133844 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"754_CR78","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1210\/endrev\/bnab012","volume":"42","author":"N di Clemente","year":"2021","unstructured":"di Clemente, N., Racine, C., Pierre, A. & Taieb, J. Anti-mullerian hormone in female reproduction. Endocr. Rev. 42, 753\u2013782 (2021).","journal-title":"Endocr. Rev."},{"key":"754_CR79","doi-asserted-by":"publisher","first-page":"a023002","DOI":"10.1101\/cshperspect.a023002","volume":"6","author":"H Du","year":"2015","unstructured":"Du, H. & Taylor, H. S. The role of hox genes in female reproductive tract development, adult function, and fertility. Cold Spring Harb. Perspect. Med. 6, a023002 (2015).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"754_CR80","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/(SICI)1520-6300(200003\/04)12:2<151::AID-AJHB1>3.0.CO;2-F","volume":"12","author":"M Blackless","year":"2000","unstructured":"Blackless, M. et al. How sexually dimorphic are we? Review and synthesis. Am. J. Hum. Biol. 12, 151\u2013166 (2000).","journal-title":"Am. J. Hum. Biol."},{"key":"754_CR81","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1080\/00224490209552139","volume":"39","author":"L Sax","year":"2002","unstructured":"Sax, L. How common is intersex? A response to Anne Fausto-Sterling. J. Sex. Res. 39, 174\u2013178 (2002).","journal-title":"J. Sex. Res."},{"key":"754_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1105-y","volume":"17","author":"S Eggers","year":"2016","unstructured":"Eggers, S. et al. Disorders of sex development: insights from targeted gene sequencing of a large international patient cohort. Genome Biol. 17, 243 (2016).","journal-title":"Genome Biol."},{"key":"754_CR83","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41443-022-00606-z","volume":"35","author":"GS Conway","year":"2023","unstructured":"Conway, G. S. Differences in sex development (DSD) and related conditions: mechanisms, prevalences and changing practice. Int. J. Impot. Res. 35, 46\u201350 (2023).","journal-title":"Int. J. Impot. Res."},{"key":"754_CR84","first-page":"195","volume":"66","author":"U Thyen","year":"2006","unstructured":"Thyen, U., Lanz, K., Holterhus, P. M. & Hiort, O. Epidemiology and initial management of ambiguous genitalia at birth in Germany. Horm. Res. 66, 195\u2013203 (2006).","journal-title":"Horm. Res."},{"key":"754_CR85","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/02724936.1991.11747526","volume":"11","author":"MA Abdullah","year":"1991","unstructured":"Abdullah, M. A. et al. Ambiguous genitalia: medical, socio-cultural and religious factors affecting management in Saudi Arabia. Ann. Trop. Paediatr. 11, 343\u2013348 (1991).","journal-title":"Ann. Trop. Paediatr."},{"key":"754_CR86","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1210\/js.2018-00408","volume":"3","author":"BK Aydin","year":"2019","unstructured":"Aydin, B. K. et al. Frequency of ambiguous genitalia in 14,177 newborns in Turkey. J. Endocr. Soc. 3, 1185\u20131195 (2019).","journal-title":"J. Endocr. Soc."},{"key":"754_CR87","first-page":"118","volume":"70","author":"I Mazen","year":"2008","unstructured":"Mazen, I., Hiort, O., Bassiouny, R. & El Gammal, M. Differential diagnosis of disorders of sex development in Egypt. Horm. Res. 70, 118\u2013123 (2008).","journal-title":"Horm. Res."},{"key":"754_CR88","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jpurol.2021.02.021","volume":"17","author":"DE Nassau","year":"2021","unstructured":"Nassau, D. E. et al. Androgenization in Klinefelter syndrome: clinical spectrum from infancy through young adulthood. J. Pediatr. Urol. 17, 346\u2013352 (2021).","journal-title":"J. Pediatr. Urol."},{"key":"754_CR89","doi-asserted-by":"publisher","DOI":"10.1159\/000519323","author":"H Syryn","year":"2021","unstructured":"Syryn, H., Van De Vijver, K. & Cools, M. Ovotesticular difference of sex development: genetic background, histological features, and clinical management. Horm. Res. Paediatr. https:\/\/doi.org\/10.1159\/000519323 (2021).","journal-title":"Horm. Res. Paediatr."},{"key":"754_CR90","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/ajmg.c.31805","volume":"184","author":"A Berglund","year":"2020","unstructured":"Berglund, A., Stochholm, K. & Gravholt, C. H. The epidemiology of sex chromosome abnormalities. Am. J. Med. Genet. C. Semin. Med. Genet. 184, 202\u2013215 (2020).","journal-title":"Am. J. Med. Genet. C. Semin. Med. Genet."},{"key":"754_CR91","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41574-019-0224-4","volume":"15","author":"CH Gravholt","year":"2019","unstructured":"Gravholt, C. H., Viuff, M. H., Brun, S., Stochholm, K. & Andersen, N. H. Turner syndrome: mechanisms and management. Nat. Rev. Endocrinol. 15, 601\u2013614 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"754_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd8110138","author":"AC Huang","year":"2021","unstructured":"Huang, A. C., Olson, S. B. & Maslen, C. L. A review of recent developments in turner syndrome research. J. Cardiovasc. Dev. Dis. https:\/\/doi.org\/10.3390\/jcdd8110138 (2021).","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"754_CR93","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/ajmg.c.31786","volume":"184","author":"M Zitzmann","year":"2020","unstructured":"Zitzmann, M. & Rohayem, J. Gonadal dysfunction and beyond: clinical challenges in children, adolescents, and adults with 47,XXY Klinefelter syndrome. Am. J. Med. Genet. C. Semin. Med. Genet. 184, 302\u2013312 (2020).","journal-title":"Am. J. Med. Genet. C. Semin. Med. Genet."},{"key":"754_CR94","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41574-018-0010-8","volume":"14","author":"M Cools","year":"2018","unstructured":"Cools, M. et al. Caring for individuals with a difference of sex development (DSD): a Consensus Statement. Nat. Rev. Endocrinol. 14, 415\u2013429 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"754_CR95","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.galenos.2021.2021-9-19","author":"N Akcan","year":"2022","unstructured":"Akcan, N. et al. Mutations in AR or SRD5A2 Genes: clinical findings, endocrine pitfalls, and genetic features of children with 46,XY DSD. J. Clin. Res. Pediatr. Endocrinol. https:\/\/doi.org\/10.4274\/jcrpe.galenos.2021.2021-9-19 (2022).","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"754_CR96","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1210\/jc.2016-2248","volume":"101","author":"A Berglund","year":"2016","unstructured":"Berglund, A. et al. Incidence, prevalence, diagnostic delay, and clinical presentation of female 46,XY disorders of sex development. J. Clin. Endocrinol. Metab. 101, 4532\u20134540 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"754_CR97","doi-asserted-by":"publisher","first-page":"731107","DOI":"10.3389\/fendo.2021.731107","volume":"12","author":"Y Peng","year":"2021","unstructured":"Peng, Y. et al. Identification of potential genes in pathogenesis and diagnostic value analysis of partial androgen insensitivity syndrome using bioinformatics analysis. Front. Endocrinol. 12, 731107 (2021).","journal-title":"Front. Endocrinol."},{"key":"754_CR98","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/S0015-0282(16)53579-1","volume":"53","author":"A Ulloa-Aguirre","year":"1990","unstructured":"Ulloa-Aguirre, A. et al. Incomplete regression of mullerian ducts in the androgen insensitivity syndrome. Fertil. Steril. 53, 1024\u20131028 (1990).","journal-title":"Fertil. Steril."},{"key":"754_CR99","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00431-003-1301-0","volume":"162","author":"YH Van","year":"2003","unstructured":"Van, Y. H. et al. Novel point mutations in complete androgen insensitivity syndrome with incomplete mullerian regression: two Taiwanese patients. Eur. J. Pediatr. 162, 781\u2013784 (2003).","journal-title":"Eur. J. Pediatr."},{"key":"754_CR100","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1515\/JPEM.2002.15.9.1553","volume":"15","author":"D Damiani","year":"2002","unstructured":"Damiani, D. et al. Persistence of Mullerian remnants in complete androgen insensitivity syndrome. J. Pediatr. Endocrinol. Metab. 15, 1553\u20131556 (2002).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"754_CR101","doi-asserted-by":"publisher","first-page":"932 e915","DOI":"10.1016\/j.fertnstert.2008.09.027","volume":"91","author":"JL Nichols","year":"2009","unstructured":"Nichols, J. L., Bieber, E. J. & Gell, J. S. Case of sisters with complete androgen insensitivity syndrome and discordant Mullerian remnants. Fertil. Steril. 91, 932 e915\u2013932 e938 (2009).","journal-title":"Fertil. Steril."},{"key":"754_CR102","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1210\/jc.2009-2146","volume":"95","author":"L Audi","year":"2010","unstructured":"Audi, L. et al. Novel (60%) and recurrent (40%) androgen receptor gene mutations in a series of 59 patients with a 46,XY disorder of sex development. J. Clin. Endocrinol. Metab. 95, 1876\u20131888 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"754_CR103","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.fertnstert.2009.03.057","volume":"94","author":"P Philibert","year":"2010","unstructured":"Philibert, P. et al. Complete androgen insensitivity syndrome is frequently due to premature stop codons in exon 1 of the androgen receptor gene: an international collaborative report of 13 new mutations. Fertil. Steril. 94, 472\u2013476 (2010).","journal-title":"Fertil. Steril."},{"key":"754_CR104","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1515\/jpem-2013-0047","volume":"26","author":"A Guven","year":"2013","unstructured":"Guven, A., Dursun, F., Ozkanli, S., Gucluer, B. & Kuru, L. I. Complete androgen insensitivity syndrome and discordant Mullerian remnants: two cases with novel mutation in the androgen receptor. J. Pediatr. Endocrinol. Metab. 26, 909\u2013914 (2013).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"754_CR105","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0015-0282(16)48626-7","volume":"43","author":"ST Dodge","year":"1985","unstructured":"Dodge, S. T., Finkelston, M. S. & Miyazawa, K. Testicular feminization with incomplete Mullerian regression. Fertil. Steril. 43, 937\u2013938 (1985).","journal-title":"Fertil. Steril."},{"key":"754_CR106","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/humu.22046","volume":"33","author":"B Gottlieb","year":"2012","unstructured":"Gottlieb, B., Beitel, L. K., Nadarajah, A., Paliouras, M. & Trifiro, M. The androgen receptor gene mutations database: 2012 update. Hum. Mutat. 33, 887\u2013894 (2012).","journal-title":"Hum. Mutat."},{"key":"754_CR107","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000519047","volume":"16","author":"A Kumar","year":"2022","unstructured":"Kumar, A. et al. Clinical, biochemical, and molecular characterization of Indian children with clinically suspected androgen insensitivity syndrome. Sex. Dev. 16, 34\u201345 (2022).","journal-title":"Sex. Dev."},{"key":"754_CR108","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0140-6736(12)60071-3","volume":"380","author":"IA Hughes","year":"2012","unstructured":"Hughes, I. A. et al. Androgen insensitivity syndrome. Lancet 380, 1419\u20131428 (2012).","journal-title":"Lancet"},{"key":"754_CR109","first-page":"232696","volume":"2013","author":"A Pizzo","year":"2013","unstructured":"Pizzo, A., Lagana, A. S., Borrielli, I. & Dugo, N. Complete androgen insensitivity syndrome: a rare case of disorder of sex development. Case Rep. Obstet. Gynecol. 2013, 232696 (2013).","journal-title":"Case Rep. Obstet. Gynecol."},{"key":"754_CR110","doi-asserted-by":"publisher","first-page":"11036","DOI":"10.12998\/wjcc.v9.i35.11036","volume":"9","author":"KN Wang","year":"2021","unstructured":"Wang, K. N., Chen, Q. Q., Zhu, Y. L. & Wang, C. L. Complete androgen insensitivity syndrome caused by the c.2678C>T mutation in the androgen receptor gene: a case report. World J. Clin. Cases 9, 11036\u201311042 (2021).","journal-title":"World J. Clin. Cases"},{"key":"754_CR111","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/cts.13184","volume":"15","author":"B Han","year":"2022","unstructured":"Han, B. et al. Differences of adrenal-derived androgens in 5\u03b1-reductase deficiency versus androgen insensitivity syndrome. Clin. Transl. Sci. 15, 658\u2013666 (2022).","journal-title":"Clin. Transl. Sci."},{"key":"754_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218403","author":"E Ilaslan","year":"2020","unstructured":"Ilaslan, E. et al. The FKBP4 gene, encoding a regulator of the androgen receptor signaling pathway, is a novel candidate gene for androgen insensitivity syndrome. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21218403 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"754_CR113","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.1210\/jc.2016-1990","volume":"101","author":"NC Hornig","year":"2016","unstructured":"Hornig, N. C. et al. Identification of an AR mutation-negative class of androgen insensitivity by determining endogenous AR activity. J. Clin. Endocrinol. Metab. 101, 4468\u20134477 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"754_CR114","doi-asserted-by":"publisher","first-page":"111146","DOI":"10.1016\/j.mce.2020.111146","volume":"523","author":"NC Hornig","year":"2021","unstructured":"Hornig, N. C. & Holterhus, P. M. Molecular basis of androgen insensitivity syndromes. Mol. Cell. Endocrinol. 523, 111146 (2021).","journal-title":"Mol. Cell. Endocrinol."},{"key":"754_CR115","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000477921","volume":"11","author":"M Cools","year":"2017","unstructured":"Cools, M. & Looijenga, L. Update on the pathophysiology and risk factors for the development of malignant testicular germ cell tumors in complete androgen insensitivity syndrome. Sex. Dev. 11, 175\u2013181 (2017).","journal-title":"Sex. Dev."},{"key":"754_CR116","doi-asserted-by":"publisher","first-page":"19","DOI":"10.6065\/apem.2040170.085","volume":"26","author":"BA Barros","year":"2021","unstructured":"Barros, B. A. et al. Complete androgen insensitivity syndrome and risk of gonadal malignancy: systematic review. Ann. Pediatr. Endocrinol. Metab. 26, 19\u201323 (2021).","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"key":"754_CR117","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1210\/er.2006-0005","volume":"27","author":"M Cools","year":"2006","unstructured":"Cools, M., Drop, S. L., Wolffenbuttel, K. P., Oosterhuis, J. W. & Looijenga, L. H. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr. Rev. 27, 468\u2013484 (2006).","journal-title":"Endocr. Rev."},{"key":"754_CR118","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000478082","volume":"11","author":"U Dohnert","year":"2017","unstructured":"Dohnert, U., Wunsch, L. & Hiort, O. Gonadectomy in complete androgen insensitivity syndrome: why and when? Sex. Dev. 11, 171\u2013174 (2017).","journal-title":"Sex. Dev."},{"key":"754_CR119","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/j.1471-0528.2008.01703.x","volume":"115","author":"L Michala","year":"2008","unstructured":"Michala, L., Goswami, D., Creighton, S. M. & Conway, G. S. Swyer syndrome: presentation and outcomes. BJOG 115, 737\u2013741 (2008).","journal-title":"BJOG"},{"key":"754_CR120","doi-asserted-by":"publisher","first-page":"480724","DOI":"10.1155\/2014\/480724","volume":"2014","author":"J Gabriel Ribeiro de Andrade","year":"2014","unstructured":"Gabriel Ribeiro de Andrade, J. et al. Long-term follow-up of patients with 46,XY partial gonadal dysgenesis reared as males. Int. J. Endocrinol. 2014, 480724 (2014).","journal-title":"Int. J. Endocrinol."},{"key":"754_CR121","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s00431-012-1754-0","volume":"171","author":"G Ocal","year":"2012","unstructured":"Ocal, G. et al. The clinical and genetic heterogeneity of mixed gonadal dysgenesis: does \u201cdisorders of sexual development (DSD)\u201d classification based on new Chicago consensus cover all sex chromosome DSD? Eur. J. Pediatr. 171, 1497\u20131502 (2012).","journal-title":"Eur. J. Pediatr."},{"key":"754_CR122","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s13224-021-01448-3","volume":"71","author":"DV Das","year":"2021","unstructured":"Das, D. V. & Jabbar, P. K. Clinical and reproductive characteristics of patients with mixed gonadal dysgenesis (45,X\/46, XY). J. Obstet. Gynaecol. India 71, 399\u2013405 (2021).","journal-title":"J. Obstet. Gynaecol. India"},{"key":"754_CR123","first-page":"739","volume":"34","author":"S Fine","year":"2021","unstructured":"Fine, S. et al. Mixed gonadal dysgenesis with an ovotestis on imaging mimicking ovotesticular disorder of sexual differentiation. Proc 34, 739\u2013741 (2021).","journal-title":"Proc"},{"key":"754_CR124","doi-asserted-by":"publisher","first-page":"150841","DOI":"10.1016\/j.sempedsurg.2019.150841","volume":"28","author":"EM Weidler","year":"2019","unstructured":"Weidler, E. M., Pearson, M., van Leeuwen, K. & Garvey, E. Clinical management in mixed gonadal dysgenesis with chromosomal mosaicism: considerations in newborns and adolescents. Semin. Pediatr. Surg. 28, 150841 (2019).","journal-title":"Semin. Pediatr. Surg."},{"key":"754_CR125","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1210\/jc.2018-02752","volume":"104","author":"ML Ljubicic","year":"2019","unstructured":"Ljubicic, M. L. et al. Clinical but not histological outcomes in males with 45,X\/46,XY mosaicism vary depending on reason for diagnosis. J. Clin. Endocrinol. Metab. 104, 4366\u20134381 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"754_CR126","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4103\/2230-8210.179999","volume":"20","author":"C Vasundhera","year":"2016","unstructured":"Vasundhera, C., Jyotsna, V. P., Kandasamy, D. & Gupta, N. Clinical, hormonal and radiological profile of 46XY disorders of sexual development. Indian. J. Endocrinol. Metab. 20, 300\u2013307 (2016).","journal-title":"Indian. J. Endocrinol. Metab."},{"key":"754_CR127","doi-asserted-by":"publisher","first-page":"101633","DOI":"10.1016\/j.beem.2022.101633","volume":"36","author":"M Elzaiat","year":"2022","unstructured":"Elzaiat, M., McElreavey, K. & Bashamboo, A. Genetics of 46,XY gonadal dysgenesis. Best. Pract. Res. Clin. Endocrinol. Metab. 36, 101633 (2022).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"754_CR128","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/cge.14086","volume":"101","author":"U Altunoglu","year":"2022","unstructured":"Altunoglu, U. et al. Expanding the spectrum of syndromic PPP2R3C-related XY gonadal dysgenesis to XX gonadal dysgenesis. Clin. Genet. 101, 221\u2013232 (2022).","journal-title":"Clin. Genet."},{"key":"754_CR129","doi-asserted-by":"publisher","DOI":"10.1159\/000520366","author":"I Mazen","year":"2022","unstructured":"Mazen, I. et al. A homozygous missense variant in hedgehog acyltransferase (HHAT) gene associated with 46,XY gonadal dysgenesis. Sex. Dev. https:\/\/doi.org\/10.1159\/000520366 (2022).","journal-title":"Sex. Dev."},{"key":"754_CR130","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/ejhg.2011.204","volume":"20","author":"S White","year":"2012","unstructured":"White, S. et al. A multi-exon deletion within WWOX is associated with a 46,XY disorder of sex development. Eur. J. Hum. Genet. 20, 348\u2013351 (2012).","journal-title":"Eur. J. Hum. Genet."},{"key":"754_CR131","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/gim.2017.163","volume":"20","author":"D Baetens","year":"2018","unstructured":"Baetens, D. et al. Biallelic and monoallelic ESR2 variants associated with 46,XY disorders of sex development. Genet. Med. 20, 717\u2013727 (2018).","journal-title":"Genet. Med."},{"key":"754_CR132","doi-asserted-by":"publisher","DOI":"10.1159\/000524956","author":"H Fabbri-Scallet","year":"2022","unstructured":"Fabbri-Scallet, H. et al. Can non-coding NR5A1 gene variants explain phenotypes of disorders of sex development? Sex. Dev. https:\/\/doi.org\/10.1159\/000524956 (2022).","journal-title":"Sex. Dev."},{"key":"754_CR133","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1002\/humu.23603","volume":"39","author":"R Sreenivasan","year":"2018","unstructured":"Sreenivasan, R. et al. Mutant NR5A1\/SF-1 in patients with disorders of sex development shows defective activation of the SOX9 TESCO enhancer. Hum. Mutat. 39, 1861\u20131874 (2018).","journal-title":"Hum. Mutat."},{"key":"754_CR134","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000522004","volume":"16","author":"K McElreavey","year":"2022","unstructured":"McElreavey, K., Pailhoux, E. & Bashamboo, A. DHX37 and 46,XY DSD: a new ribosomopathy? Sex. Dev. 16, 194\u2013206 (2022).","journal-title":"Sex. Dev."},{"key":"754_CR135","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1210\/jc.2019-00984","volume":"104","author":"TE da Silva","year":"2019","unstructured":"da Silva, T. E. et al. Genetic evidence of the association of DEAH-box helicase 37 defects with 46,XY gonadal dysgenesis spectrum. J. Clin. Endocrinol. Metab. 104, 5923\u20135934 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"754_CR136","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1093\/hmg\/ddr109","volume":"20","author":"S Bagheri-Fam","year":"2011","unstructured":"Bagheri-Fam, S. et al. Defective survival of proliferating Sertoli cells and androgen receptor function in a mouse model of the ATR-X syndrome. Hum. Mol. Genet. 20, 2213\u20132224 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"754_CR137","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/mrd.1080390211","volume":"39","author":"VR Harley","year":"1994","unstructured":"Harley, V. R. & Goodfellow, P. N. The biochemical role of SRY in sex determination. Mol. Reprod. Dev. 39, 184\u2013193 (1994).","journal-title":"Mol. Reprod. Dev."},{"key":"754_CR138","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10577-011-9256-x","volume":"20","author":"L Zhao","year":"2012","unstructured":"Zhao, L. & Koopman, P. SRY protein function in sex determination: thinking outside the box. Chromosome Res. 20, 153\u2013162 (2012).","journal-title":"Chromosome Res."},{"key":"754_CR139","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jmb.2006.01.060","volume":"358","author":"NB Phillips","year":"2006","unstructured":"Phillips, N. B. et al. SRY and human sex determination: the basic tail of the HMG box functions as a kinetic clamp to augment DNA bending. J. Mol. Biol. 358, 172\u2013192 (2006).","journal-title":"J. Mol. Biol."},{"key":"754_CR140","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1093\/hmg\/ddz002","volume":"28","author":"A Chamberlin","year":"2019","unstructured":"Chamberlin, A. et al. Mutations in MAP3K1 that cause 46,XY disorders of sex development disrupt distinct structural domains in the protein. Hum. Mol. Genet. 28, 1620\u20131628 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"754_CR141","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.devcel.2012.09.016","volume":"23","author":"N Warr","year":"2012","unstructured":"Warr, N. et al. Gadd45\u03b3 and Map3k4 interactions regulate mouse testis determination via p38 MAPK-mediated control of Sry expression. Dev. Cell 23, 1020\u20131031 (2012).","journal-title":"Dev. Cell"},{"key":"754_CR142","doi-asserted-by":"publisher","first-page":"E1171","DOI":"10.1210\/jc.2011-0232","volume":"96","author":"M Cools","year":"2011","unstructured":"Cools, M. et al. Gonadal pathology and tumor risk in relation to clinical characteristics in patients with 45,X\/46,XY mosaicism. J. Clin. Endocrinol. Metab. 96, E1171\u2013E1180 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"754_CR143","doi-asserted-by":"publisher","first-page":"856128","DOI":"10.3389\/fped.2022.856128","volume":"10","author":"L Lu","year":"2022","unstructured":"Lu, L., Luo, F. & Wang, X. Gonadal tumor risk in pediatric and adolescent phenotypic females with disorders of sex development and Y chromosomal constitution with different genetic etiologies. Front. Pediatr. 10, 856128 (2022).","journal-title":"Front. Pediatr."},{"key":"754_CR144","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/cen.13255","volume":"86","author":"H Huang","year":"2017","unstructured":"Huang, H., Wang, C. & Tian, Q. Gonadal tumour risk in 292 phenotypic female patients with disorders of sex development containing Y chromosome or Y-derived sequence. Clin. Endocrinol. 86, 621\u2013627 (2017).","journal-title":"Clin. Endocrinol."},{"key":"754_CR145","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/TACG.S198178","volume":"13","author":"RL Batista","year":"2020","unstructured":"Batista, R. L. & Mendonca, B. B. Integrative and analytical review of the 5-alpha-reductase type 2 deficiency worldwide. Appl. Clin. Genet. 13, 83\u201396 (2020).","journal-title":"Appl. Clin. Genet."},{"key":"754_CR146","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.2047-2927.2014.00215.x","volume":"2","author":"T Akcay","year":"2014","unstructured":"Akcay, T. et al. AR and SRD5A2 gene mutations in a series of 51 Turkish 46,XY DSD children with a clinical diagnosis of androgen insensitivity. Andrology 2, 572\u2013578 (2014).","journal-title":"Andrology"},{"key":"754_CR147","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2265.1995.tb01913.x","volume":"43","author":"C Boudon","year":"1995","unstructured":"Boudon, C. et al. A new deletion of the 5\u03b1-reductase type 2 gene in a Turkish family with 5 \u03b1-reductase deficiency. Clin. Endocrinol. 43, 183\u2013188 (1995).","journal-title":"Clin. Endocrinol."},{"key":"754_CR148","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1515\/JPEM.2002.15.4.411","volume":"15","author":"G Ocal","year":"2002","unstructured":"Ocal, G. et al. Mutations of the 5\u03b1-steroid reductase type 2 gene in six Turkish patients from unrelated families and a large pedigree of an isolated Turkish village. J. Pediatr. Endocrinol. Metab. 15, 411\u2013421 (2002).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"754_CR149","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/molehr\/gaq072","volume":"17","author":"M Nie","year":"2011","unstructured":"Nie, M., Zhou, Q., Mao, J., Lu, S. & Wu, X. Five novel mutations of SRD5A2 found in eight Chinese patients with 46,XY disorders of sex development. Mol. Hum. Reprod. 17, 57\u201362 (2011).","journal-title":"Mol. Hum. Reprod."},{"key":"754_CR150","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/cen.12456","volume":"81","author":"H Zhu","year":"2014","unstructured":"Zhu, H. et al. Phenotypic and molecular characteristics in eleven Chinese patients with 5\u03b1-reductase type 2 deficiency. Clin. Endocrinol. 81, 711\u2013720 (2014).","journal-title":"Clin. Endocrinol."},{"key":"754_CR151","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000445090","volume":"10","author":"S Bertelloni","year":"2016","unstructured":"Bertelloni, S. et al. 5\u03b1-reductase-2 deficiency: clinical findings, endocrine pitfalls, and genetic features in a large Italian cohort. Sex. Dev. 10, 28\u201336 (2016).","journal-title":"Sex. Dev."},{"key":"754_CR152","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1126\/science.186.4170.1213","volume":"186","author":"J Imperato-McGinley","year":"1974","unstructured":"Imperato-McGinley, J., Guerrero, L., Gautier, T. & Peterson, R. E. Steroid 5\u03b1-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 186, 1213\u20131215 (1974).","journal-title":"Science"},{"key":"754_CR153","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000271915","volume":"73","author":"JM Ko","year":"2010","unstructured":"Ko, J. M. et al. Clinical characterization and analysis of the SRD5A2 gene in six Korean patients with 5\u03b1-reductase type 2 deficiency. Horm. Res. Paediatr. 73, 41\u201348 (2010).","journal-title":"Horm. Res. Paediatr."},{"key":"754_CR154","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/00005792-199603000-00003","volume":"75","author":"BB Mendonca","year":"1996","unstructured":"Mendonca, B. B. et al. Male pseudohermaphroditism due to steroid 5\u03b1-reductase 2 deficiency. Diagnosis, psychological evaluation, and management. Medicine 75, 64\u201376 (1996).","journal-title":"Medicine"},{"key":"754_CR155","doi-asserted-by":"publisher","first-page":"2015.e11","DOI":"10.1016\/j.fertnstert.2008.01.019","volume":"90","author":"T Sahakitrungruang","year":"2008","unstructured":"Sahakitrungruang, T. et al. Identification of mutations in the SRD5A2 gene in Thai patients with male pseudohermaphroditism. Fertil. Steril. 90, 2015.e11\u20132015.e15 (2008).","journal-title":"Fertil. Steril."},{"key":"754_CR156","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1046\/j.1365-2265.1997.800904.x","volume":"46","author":"P Canto","year":"1997","unstructured":"Canto, P. et al. Mutations of the 5\u03b1-reductase type 2 gene in eight Mexican patients from six different pedigrees with 5\u03b1-reductase-2 deficiency. Clin. Endocrinol. 46, 155\u2013160 (1997).","journal-title":"Clin. Endocrinol."},{"key":"754_CR157","doi-asserted-by":"publisher","first-page":"794476","DOI":"10.3389\/fgene.2021.794476","volume":"12","author":"OL Maria Guadalupe","year":"2021","unstructured":"Maria Guadalupe, O. L., Katy, S. P., Charmina, A. A., Vihko, P. & Marta, M. Molecular characterization of two known SRD5A2 gene variants in Mexican patients with disorder of sexual development. Front. Genet. 12, 794476 (2021).","journal-title":"Front. Genet."},{"key":"754_CR158","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2164\/jandrol.109.009407","volume":"31","author":"F Vilchis","year":"2010","unstructured":"Vilchis, F. et al. Molecular analysis of the SRD5A2 in 46,XY subjects with incomplete virilization: the P212R substitution of the steroid 5\u03b1-reductase 2 may constitute an ancestral founder mutation in Mexican patients. J. Androl. 31, 358\u2013364 (2010).","journal-title":"J. Androl."},{"key":"754_CR159","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000454974","volume":"11","author":"S Andonova","year":"2017","unstructured":"Andonova, S. et al. New territory for an old disease: 5-\u03b1-reductase type 2 deficiency in Bulgaria. Sex. Dev. 11, 21\u201328 (2017).","journal-title":"Sex. Dev."},{"key":"754_CR160","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/ahg.12358","volume":"84","author":"A Avendano","year":"2020","unstructured":"Avendano, A. et al. 5\u03b1-Reductase type 2 deficiency in families from an isolated Andean population in Venezuela. Ann. Hum. Genet. 84, 151\u2013160 (2020).","journal-title":"Ann. Hum. Genet."},{"key":"754_CR161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00431-010-1189-4","volume":"170","author":"CK Cheon","year":"2011","unstructured":"Cheon, C. K. Practical approach to steroid 5\u03b1-reductase type 2 deficiency. Eur. J. Pediatr. 170, 1\u20138 (2011).","journal-title":"Eur. J. Pediatr."},{"key":"754_CR162","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0303-7207(02)00368-4","volume":"198","author":"J Imperato-McGinley","year":"2002","unstructured":"Imperato-McGinley, J. & Zhu, Y. S. Androgens and male physiology the syndrome of 5\u03b1-reductase-2 deficiency. Mol. Cell Endocrinol. 198, 51\u201359 (2002).","journal-title":"Mol. Cell Endocrinol."},{"key":"754_CR163","first-page":"577","volume":"14","author":"JD Wilson","year":"1993","unstructured":"Wilson, J. D., Griffin, J. E. & Russell, D. W. Steroid 5 \u03b1-reductase 2 deficiency. Endocr. Rev. 14, 577\u2013593 (1993).","journal-title":"Endocr. Rev."},{"key":"754_CR164","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1210\/jc.2010-1024","volume":"96","author":"L Maimoun","year":"2011","unstructured":"Maimoun, L. et al. Phenotypical, biological, and molecular heterogeneity of 5\u03b1-reductase deficiency: an extensive international experience of 55 patients. J. Clin. Endocrinol. Metab. 96, 296\u2013307 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"754_CR165","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1210\/jcem-48-5-821","volume":"48","author":"S Pang","year":"1979","unstructured":"Pang, S. et al. Dihydrotestosterone and its relationship to testosterone in infancy and childhood. J. Clin. Endocrinol. Metab. 48, 821\u2013826 (1979).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"754_CR166","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1055\/s-0032-1324727","volume":"30","author":"EM Costa","year":"2012","unstructured":"Costa, E. M., Domenice, S., Sircili, M. H., Inacio, M. & Mendonca, B. B. DSD due to 5\u03b1-reductase 2 deficiency \u2014 from diagnosis to long term outcome. Semin. Reprod. Med. 30, 427\u2013431 (2012).","journal-title":"Semin. Reprod. Med."},{"key":"754_CR167","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1056\/NEJM197410312911806","volume":"291","author":"PC Walsh","year":"1974","unstructured":"Walsh, P. C. et al. Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N. Engl. J. Med. 291, 944\u2013949 (1974).","journal-title":"N. Engl. J. Med."},{"key":"754_CR168","first-page":"66","volume":"42","author":"BB Mendonca","year":"1987","unstructured":"Mendonca, B. B. et al. Male pseudohermaphroditism due to 5 \u03b1 reductase deficiency associated with gynecomastia. Rev. Hosp. Clin. Fac. Med. Sao Paulo 42, 66\u201368 (1987).","journal-title":"Rev. Hosp. Clin. Fac. Med. Sao Paulo"},{"key":"754_CR169","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/andr.12636","volume":"7","author":"GA Kanakis","year":"2019","unstructured":"Kanakis, G. A. et al. EAA clinical practice guidelines \u2014 gynecomastia evaluation and management. Andrology 7, 778\u2013793 (2019).","journal-title":"Andrology"},{"key":"754_CR170","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJM197905313002201","volume":"300","author":"J Imperato-McGinley","year":"1979","unstructured":"Imperato-McGinley, J., Peterson, R. E., Gautier, T. & Sturla, E. Androgens and the evolution of male-gender identity among male pseudohermaphrodites with 5\u03b1-reductase deficiency. N. Engl. J. Med. 300, 1233\u20131237 (1979).","journal-title":"N. Engl. J. Med."},{"key":"754_CR171","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000481552","volume":"12","author":"S Bertelloni","year":"2018","unstructured":"Bertelloni, S., Russo, G. & Baroncelli, G. I. Human chorionic gonadotropin test: old uncertainties, new perspectives, and value in 46,XY disorders of sex development. Sex. Dev. 12, 41\u201349 (2018).","journal-title":"Sex. Dev."},{"key":"754_CR172","doi-asserted-by":"publisher","first-page":"e526","DOI":"10.1111\/j.1365-2605.2010.01136.x","volume":"34","author":"M Fernandez-Cancio","year":"2011","unstructured":"Fernandez-Cancio, M. et al. SRD5A2 gene mutations and polymorphisms in Spanish 46,XY patients with a disorder of sex differentiation. Int. J. Androl. 34, e526\u2013e535 (2011).","journal-title":"Int. J. Androl."},{"key":"754_CR173","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/MED.0000000000000115","volume":"21","author":"BB Mendonca","year":"2014","unstructured":"Mendonca, B. B. Gender assignment in patients with disorder of sex development. Curr. Opin. Endocrinol. Diabetes Obes. 21, 511\u2013514 (2014).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"754_CR174","first-page":"34","volume":"8","author":"R Samtani","year":"2010","unstructured":"Samtani, R., Bajpai, M., Ghosh, P. K. & Saraswathy, K. N. SRD5A2 gene mutations \u2014 a population-based review. Pediatr. Endocrinol. Rev. 8, 34\u201340 (2010).","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"754_CR175","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-14-43","volume":"14","author":"L Vija","year":"2014","unstructured":"Vija, L. et al. Testicular histological and immunohistochemical aspects in a post-pubertal patient with 5\u03b1-reductase type 2 deficiency: case report and review of the literature in a perspective of evaluation of potential fertility of these patients. BMC Endocr. Disord. 14, 43 (2014).","journal-title":"BMC Endocr. Disord."},{"key":"754_CR176","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/endrev\/bnab016","volume":"43","author":"HL Claahsen-van der Grinten","year":"2022","unstructured":"Claahsen-van der Grinten, H. L. et al. Congenital adrenal hyperplasia \u2014 current insights in pathophysiology, diagnostics, and management. Endocr. Rev. 43, 91\u2013159 (2022).","journal-title":"Endocr. Rev."},{"key":"754_CR177","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/medicina55070371","volume":"55","author":"M Terribile","year":"2019","unstructured":"Terribile, M. et al. 46,XX Testicular disorder of sex development (DSD): a case report and systematic review. Medicina 55, 371 (2019).","journal-title":"Medicina"},{"key":"754_CR178","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/MED.0000000000000727","volume":"29","author":"RJ Auchus","year":"2022","unstructured":"Auchus, R. J. The uncommon forms of congenital adrenal hyperplasia. Curr. Opin. Endocrinol. Diabetes Obes. 29, 263\u2013270 (2022).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"754_CR179","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/archdischild-2011-300234","volume":"97","author":"JM Khalid","year":"2012","unstructured":"Khalid, J. M. et al. Incidence and clinical features of congenital adrenal hyperplasia in Great Britain. Arch. Dis. Child. 97, 101\u2013106 (2012).","journal-title":"Arch. Dis. Child."},{"key":"754_CR180","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1001\/jamapediatrics.2013.5321","volume":"168","author":"S Gidl\u00f6f","year":"2014","unstructured":"Gidl\u00f6f, S., Wedell, A., Guthenberg, C., von D\u00f6beln, U. & Nordenstr\u00f6m, A. Nationwide neonatal screening for congenital adrenal hyperplasia in Sweden: a 26-year longitudinal prospective population-based study. JAMA Pediatr. 168, 567\u2013574 (2014).","journal-title":"JAMA Pediatr."},{"key":"754_CR181","doi-asserted-by":"publisher","first-page":"624507","DOI":"10.3389\/fendo.2021.624507","volume":"12","author":"Z Li","year":"2021","unstructured":"Li, Z. et al. Analysis of the screening results for congenital adrenal hyperplasia involving 7.85 million newborns in China: a systematic review and meta-analysis. Front. Endocrinol. 12, 624507 (2021).","journal-title":"Front. Endocrinol."},{"key":"754_CR182","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/S0140-6736(17)31431-9","volume":"390","author":"D El-Maouche","year":"2017","unstructured":"El-Maouche, D., Arlt, W. & Merke, D. P. Congenital adrenal hyperplasia. Lancet 390, 2194\u20132210 (2017).","journal-title":"Lancet"},{"key":"754_CR183","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S2213-8587(13)70007-X","volume":"1","author":"S Gidlof","year":"2013","unstructured":"Gidlof, S. et al. One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study. Lancet Diabetes Endocrinol. 1, 35\u201342 (2013).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"754_CR184","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJMra1909786","volume":"383","author":"DP Merke","year":"2020","unstructured":"Merke, D. P. & Auchus, R. J. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N. Engl. J. Med. 383, 1248\u20131261 (2020).","journal-title":"N. Engl. J. Med."},{"key":"754_CR185","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1210\/jc.2018-02605","volume":"104","author":"B Neeman","year":"2019","unstructured":"Neeman, B., Bello, R., Lazar, L., Phillip, M. & de Vries, L. Central precocious puberty as a presenting sign of nonclassical congenital adrenal hyperplasia: clinical characteristics. J. Clin. Endocrinol. Metab. 104, 2695\u20132700 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"754_CR186","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1067\/mpd.2001.110527","volume":"138","author":"EA Eugster","year":"2001","unstructured":"Eugster, E. A. et al. Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis. J. Pediatr. 138, 26\u201332 (2001).","journal-title":"J. Pediatr."},{"key":"754_CR187","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1210\/jc.2006-1645","volume":"91","author":"MI New","year":"2006","unstructured":"New, M. I. Extensive clinical experience: nonclassical 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 91, 4205\u20134214 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"754_CR188","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1210\/clinem\/dgab232","volume":"106","author":"BH Al Wattar","year":"2021","unstructured":"Al Wattar, B. H. et al. Clinical practice guidelines on the diagnosis and management of polycystic ovary syndrome: a systematic review and quality assessment study. J. Clin. Endocrinol. Metab. 106, 2436\u20132446 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"754_CR189","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz, R. et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J. Clin. Endocrinol. Metab. 91, 4237\u20134245 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"754_CR190","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fendo.2019.00388","volume":"10","author":"G Papadakis","year":"2019","unstructured":"Papadakis, G., Kandaraki, E. A., Tseniklidi, E., Papalou, O. & Diamanti-Kandarakis, E. Polycystic ovary syndrome and NC-CAH: distinct characteristics and common findings. A systematic review. Front. Endocrinol. 10, 388 (2019).","journal-title":"Front. Endocrinol."},{"key":"754_CR191","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41574-022-00655-w","volume":"18","author":"A Mallappa","year":"2022","unstructured":"Mallappa, A. & Merke, D. P. Management challenges and therapeutic advances in congenital adrenal hyperplasia. Nat. Rev. Endocrinol. 18, 337\u2013352 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"754_CR192","doi-asserted-by":"publisher","first-page":"e2063","DOI":"10.1210\/clinem\/dgab051","volume":"106","author":"DP Merke","year":"2021","unstructured":"Merke, D. P. et al. Modified-release hydrocortisone in congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 106, e2063\u2013e2077 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"754_CR193","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/cen.12316","volume":"80","author":"M Whitaker","year":"2014","unstructured":"Whitaker, M. et al. An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure. Clin. Endocrinol. 80, 554\u2013561 (2014).","journal-title":"Clin. Endocrinol."},{"key":"754_CR194","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.celrep.2018.01.003","volume":"22","author":"G Ruiz-Babot","year":"2018","unstructured":"Ruiz-Babot, G. et al. Modeling congenital adrenal hyperplasia and testing interventions for adrenal insufficiency using donor-specific reprogrammed cells. Cell Rep. 22, 1236\u20131249 (2018).","journal-title":"Cell Rep."},{"key":"754_CR195","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1089\/hum.2017.203","volume":"29","author":"S Markmann","year":"2018","unstructured":"Markmann, S. et al. Biology of the adrenal gland cortex obviates effective use of adeno-associated virus vectors to treat hereditary adrenal disorders. Hum. Gene Ther. 29, 403\u2013412 (2018).","journal-title":"Hum. Gene Ther."},{"key":"754_CR196","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/ClinicalTrials.gov\/show\/NCT04783181 (2023)."},{"key":"754_CR197","doi-asserted-by":"publisher","first-page":"A60","DOI":"10.1210\/jendso\/bvac150.125","volume":"6","author":"K Bharucha","year":"2022","unstructured":"Bharucha, K. et al. ODP046 Initial lessons from a prescreening protocol to identify participants with classic CAH potentially eligible for gene therapy treatment with BBP-631, an adeno-associated virus (AAV) serotype 5-Based Recombinant Vector Encoding the Human CYP21A2 Gene. J. Endocr. Soc. 6, A60\u2013A61 (2022).","journal-title":"J. Endocr. Soc."},{"key":"754_CR198","doi-asserted-by":"publisher","first-page":"K13","DOI":"10.1530\/EJE-21-0913","volume":"187","author":"M Yildiz","year":"2022","unstructured":"Yildiz, M. et al. Ovarian and paraovarian adrenal rest tumors are not uncommon in gonadectomy materials of historical congenital adrenal hyperplasia cases in childhood. Eur. J. Endocrinol. 187, K13\u2013K18 (2022).","journal-title":"Eur. J. Endocrinol."},{"key":"754_CR199","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.4158\/EP-2020-0058","volume":"26","author":"I Nermoen","year":"2020","unstructured":"Nermoen, I. & Falhammar, H. Prevalence and characteristics of adrenal tumors and myelolipomas in congenital adrenal hyperplasia: a systematic review and meta-analysis. Endocr. Pract. 26, 1351\u20131365 (2020).","journal-title":"Endocr. Pract."},{"key":"754_CR200","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.juro.2016.09.072","volume":"197","author":"MS Kim","year":"2017","unstructured":"Kim, M. S. et al. Testicular adrenal rest tumors in boys and young adults with congenital adrenal hyperplasia. J. Urol. 197, 931\u2013936 (2017).","journal-title":"J. Urol."},{"key":"754_CR201","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1210\/jc.2007-1115","volume":"93","author":"AT Maciel-Guerra","year":"2008","unstructured":"Maciel-Guerra, A. T. et al. XX Maleness and XX true hermaphroditism in SRY-negative monozygotic twins: additional evidence for a common origin. J. Clin. Endocrinol. Metab. 93, 339\u2013343 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"754_CR202","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000485393","volume":"11","author":"Y Naasse","year":"2017","unstructured":"Naasse, Y. et al. A novel homozygous missense mutation in the FU-CRD2 domain of the R-spondin1 gene associated with familial 46,XX DSD. Sex. Dev. 11, 269\u2013274 (2017).","journal-title":"Sex. Dev."},{"key":"754_CR203","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000445088","volume":"10","author":"RP Grinspon","year":"2016","unstructured":"Grinspon, R. P. & Rey, R. A. Disorders of sex development with testicular differentiation in SRY-negative 46,XX individuals: clinical and genetic aspects. Sex. Dev. 10, 1\u201311 (2016).","journal-title":"Sex. Dev."},{"key":"754_CR204","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1093\/humrep\/dex210","volume":"32","author":"A Berglund","year":"2017","unstructured":"Berglund, A. et al. Incidence, prevalence, diagnostic delay, morbidity, mortality and socioeconomic status in males with 46,XX disorders of sex development: a nationwide study. Hum. Reprod. 32, 1751\u20131760 (2017).","journal-title":"Hum. Reprod."},{"key":"754_CR205","doi-asserted-by":"publisher","first-page":"13680","DOI":"10.1073\/pnas.1921676117","volume":"117","author":"C Eozenou","year":"2020","unstructured":"Eozenou, C. et al. Testis formation in XX individuals resulting from novel pathogenic variants in Wilms\u2019 tumor 1 (WT1) gene. Proc. Natl Acad. Sci. USA 117, 13680\u201313688 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"754_CR206","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-022-01347-0","volume":"15","author":"J Wei","year":"2022","unstructured":"Wei, J. et al. Duplication of SOX3 in an SRY-negative 46,XX male with prostatic utricle: case report and literature review. BMC Med. Genomics 15, 188 (2022).","journal-title":"BMC Med. Genomics"},{"key":"754_CR207","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/cge.13459","volume":"95","author":"NL Gomes","year":"2019","unstructured":"Gomes, N. L. et al. A 46,XX testicular disorder of sex development caused by a Wilms\u2019 tumour Factor-1 (WT1) pathogenic variant. Clin. Genet. 95, 172\u2013176 (2019).","journal-title":"Clin. Genet."},{"key":"754_CR208","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/ajmg.a.38646","volume":"176","author":"K Tallapaka","year":"2018","unstructured":"Tallapaka, K., Venugopal, V., Dalal, A. & Aggarwal, S. Novel RSPO1 mutation causing 46,XX testicular disorder of sex development with palmoplantar keratoderma: a review of literature and expansion of clinical phenotype. Am. J. Med. Genet. A 176, 1006\u20131010 (2018).","journal-title":"Am. J. Med. Genet. A"},{"key":"754_CR209","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ng1907","volume":"38","author":"P Parma","year":"2006","unstructured":"Parma, P. et al. R-spondin1 is essential in sex determination, skin differentiation and malignancy. Nat. Genet. 38, 1304\u20131309 (2006).","journal-title":"Nat. Genet."},{"key":"754_CR210","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ajhg.2007.08.005","volume":"82","author":"H Mandel","year":"2008","unstructured":"Mandel, H. et al. SERKAL syndrome: an autosomal-recessive disorder caused by a loss-of-function mutation in WNT4. Am. J. Hum. Genet. 82, 39\u201347 (2008).","journal-title":"Am. J. Hum. Genet."},{"key":"754_CR211","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/gim.2016.118","volume":"19","author":"D Baetens","year":"2017","unstructured":"Baetens, D. et al. NR5A1 is a novel disease gene for 46,XX testicular and ovotesticular disorders of sex development. Genet. Med. 19, 367\u2013376 (2017).","journal-title":"Genet. Med."},{"key":"754_CR212","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1093\/hmg\/ddw186","volume":"25","author":"A Bashamboo","year":"2016","unstructured":"Bashamboo, A. et al. A recurrent p.Arg92Trp variant in steroidogenic factor-1 (NR5A1) can act as a molecular switch in human sex development. Hum. Mol. Genet. 25, 3446\u20133453 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"754_CR213","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/humu.23672","volume":"40","author":"IM Knarston","year":"2019","unstructured":"Knarston, I. M. et al. NR5A1 gene variants repress the ovarian-specific WNT signaling pathway in 46,XX disorders of sex development patients. Hum. Mutat. 40, 207\u2013216 (2019).","journal-title":"Hum. Mutat."},{"key":"754_CR214","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ajhg.2018.01.021","volume":"102","author":"A Bashamboo","year":"2018","unstructured":"Bashamboo, A. et al. Loss of function of the nuclear receptor NR2F2, encoding COUP-TF2, causes testis development and cardiac defects in 46,XX children. Am. J. Hum. Genet. 102, 487\u2013493 (2018).","journal-title":"Am. J. Hum. Genet."},{"key":"754_CR215","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1210\/js.2019-00241","volume":"3","author":"G Carvalheira","year":"2019","unstructured":"Carvalheira, G. et al. The natural history of a man with ovotesticular 46,XX DSD caused by a novel 3-Mb 15q26.2 deletion containing NR2F2 gene. J. Endocr. Soc. 3, 2107\u20132113 (2019).","journal-title":"J. Endocr. Soc."},{"key":"754_CR216","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1172\/JCI42580","volume":"121","author":"E Sutton","year":"2011","unstructured":"Sutton, E. et al. Identification of SOX3 as an XX male sex reversal gene in mice and humans. J. Clin. Invest. 121, 328\u2013341 (2011).","journal-title":"J. Clin. Invest."},{"key":"754_CR217","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ejhg.2014.237","volume":"23","author":"A Vetro","year":"2015","unstructured":"Vetro, A. et al. Testis development in the absence of SRY: chromosomal rearrangements at SOX9 and SOX3. Eur. J. Hum. Genet. 23, 1025\u20131032 (2015).","journal-title":"Eur. J. Hum. Genet."},{"key":"754_CR218","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJMc1010311","volume":"364","author":"JJ Cox","year":"2011","unstructured":"Cox, J. J., Willatt, L., Homfray, T. & Woods, C. G. A SOX9 duplication and familial 46,XX developmental testicular disorder. N. Engl. J. Med. 364, 91\u201393 (2011).","journal-title":"N. Engl. J. Med."},{"key":"754_CR219","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1002\/ajmg.a.62373","volume":"185","author":"Z Qian","year":"2021","unstructured":"Qian, Z. et al. Whole genome sequencing identifies a cryptic SOX9 regulatory element duplication underlying a case of 46,XX ovotesticular difference of sexual development. Am. J. Med. Genet. A 185, 2782\u20132788 (2021).","journal-title":"Am. J. Med. Genet. A"},{"key":"754_CR220","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/ajmg.a.38109","volume":"173","author":"N Falah","year":"2017","unstructured":"Falah, N. et al. 22q11.2q13 duplication including SOX10 causes sex-reversal and peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung disease. Am. J. Med. Genet. A 173, 1066\u20131070 (2017).","journal-title":"Am. J. Med. Genet. A"},{"key":"754_CR221","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/ajmg.a.20630","volume":"127a","author":"T Seeherunvong","year":"2004","unstructured":"Seeherunvong, T. et al. 46,XX sex reversal with partial duplication of chromosome arm 22q. Am. J. Med. Genet. A 127a, 149\u2013151 (2004).","journal-title":"Am. J. Med. Genet. A"},{"key":"754_CR222","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07784-9","volume":"9","author":"B Croft","year":"2018","unstructured":"Croft, B. et al. Human sex reversal is caused by duplication or deletion of core enhancers upstream of SOX9. Nat. Commun. 9, 5319 (2018).","journal-title":"Nat. Commun."},{"key":"754_CR223","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1126\/science.aas9408","volume":"360","author":"N Gonen","year":"2018","unstructured":"Gonen, N. et al. Sex reversal following deletion of a single distal enhancer of Sox9. Science 360, 1469\u20131473 (2018).","journal-title":"Science"},{"key":"754_CR224","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.stemcr.2022.01.012","volume":"17","author":"M Kobayashi","year":"2022","unstructured":"Kobayashi, M. et al. Expanding homogeneous culture of human primordial germ cell-like cells maintaining germline features without serum or feeder layers. Stem Cell Rep. 17, 507\u2013521 (2022).","journal-title":"Stem Cell Rep."},{"key":"754_CR225","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00018-020-03533-8","volume":"78","author":"W Ge","year":"2021","unstructured":"Ge, W. et al. Dissecting the initiation of female meiosis in the mouse at single-cell resolution. Cell. Mol. Life Sci. 78, 695\u2013713 (2021).","journal-title":"Cell. Mol. Life Sci."},{"key":"754_CR226","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/mgg3.445","volume":"6","author":"P Sproll","year":"2018","unstructured":"Sproll, P. et al. Assembling the jigsaw puzzle: CBX2 isoform 2 and its targets in disorders\/differences of sex development. Mol. Genet. Genom. Med. 6, 785\u2013795 (2018).","journal-title":"Mol. Genet. Genom. Med."},{"key":"754_CR227","doi-asserted-by":"publisher","DOI":"10.1111\/cge.14261","author":"B Croft","year":"2022","unstructured":"Croft, B. et al. FGF9 variant in 46,XY DSD patient suggests a role for dimerization in sex determination. Clin. Genet. https:\/\/doi.org\/10.1111\/cge.14261 (2022).","journal-title":"Clin. Genet."},{"key":"754_CR228","doi-asserted-by":"publisher","first-page":"6699","DOI":"10.1093\/hmg\/ddv374","volume":"24","author":"S Bagheri-Fam","year":"2015","unstructured":"Bagheri-Fam, S. et al. FGFR2 mutation in 46,XY sex reversal with craniosynostosis. Hum. Mol. Genet. 24, 6699\u20136710 (2015).","journal-title":"Hum. Mol. Genet."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-023-00754-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-023-00754-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-023-00754-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T16:22:16Z","timestamp":1688487736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-023-00754-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,5]]},"references-count":228,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["754"],"URL":"https:\/\/doi.org\/10.1038\/s41585-023-00754-x","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,5]]},"assertion":[{"value":"3 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}